August 2024 - Page 3 of 15

WednesdayAug 28, 2024 9:00 am

Clene Inc.’s (NASDAQ: CLNN) CEO Discusses Company’s Mission, CNM-Au8(R) Trial Results, and Future Plans on BioMedWire Podcast

Clene is pioneering a very unique approach to the treatment of neurodegenerative diseases such as ALS and MS with the use of an oral nanotherapeutic that can be easily administered The company has submitted CNM-Au8 biomarker and efficacy data to the Food and Drug Administration in a Type C meeting request, seeking approval to file a new drug application using the accelerated approval pathway for ALS CNM-Au8 has the potential to impact the ALS therapeutic market, as CNM-Au8 can help increase and improve survival rates and delay clinical worsening in ALS patients In MS, CNM-Au8 can work in conjunction with…

TuesdayAug 27, 2024 11:11 am

QualityStocksNewsBreaks – Torr Metals Inc. (TSXV: TMET) Releases Report on Final Assay Results from 2024 Reconnaissance Programs Rock Grab Samples

Torr Metals (TSX.V: TMET), a mineral exploration company focusing on the identification, acquisition and advancement of mineral properties, is reporting on the final assay results from a total of 33 rock grab samples collected during 2024 reconnaissance programs. According to the report, the samples reveal additional high-grade rock grab assays within the Kirby, Rea and Clapperton exploration target zones as well as a new copper-gold discovery in the northern portion of the Kolos Copper-Gold Project, which is now called the Sonic Zone. “The latest results from our 2024 reconnaissance sampling programs not only reaffirm the high-grade potential of the Kolos…

TuesdayAug 27, 2024 10:54 am

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Provides Update on Its Response to Extraordinary Request to Provide PAX-101 to Malawi

PaxMedica (NASDAQ: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, today announced that the first patient suffering from the potentially fatal parasitic infection known as Human Africa Trypanosomiasis Brucei Rhodesiense (“HAT”) in Malawi had been treated with PAX-101, an intravenous form of Suramin. The announcement noted that the Malawi Ministry of Health has informed PaxMedica that, following the treatment, the patient is recovering at home. The Rhodesiense strain of HAT is nearly 100% fatal if not treated promptly, and Suramin is considered the standard of care in Malawi and many East African countries. “The first use…

TuesdayAug 27, 2024 10:25 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Reports on Significant Achievements, System Activation, Expanding Network

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has released a status update. According to the announcement, the update outlines the company’s significant milestones as it “closes in on system activation and broadens its network of strategic partners.” The report includes highlights from FuelPositive’s Aug. 19, 2024, finance meeting with Adrien Sala; a project timeline update; the company’s initiative to strengthen the team, promote excellence and address challenges; recent financing developments and sales efforts; and the expansion of strategic networks. “As the company approaches critical milestones, FuelPositive is entering an exciting phase of growth and innovation,” said the…

TuesdayAug 27, 2024 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Continues to Fortify Its Financial Position and Grow in the Behavioral Health Market

Transdermal alcohol detection solutions provider SOBRsafe is implementing strategies to further strengthen its financial position During Q2 2024, the company eliminated $2.6 million in debt and improved its balance sheet with a capital infusion from the exercise of warrants SOBRsafe has increased its revenue by 44% from Q2 2023 as it continues to onboard new customers in 2024 SOBRsafe (NASDAQ: SOBR), the provider of next-generation transdermal alcohol detection solutions, has continued to implement plans and strategies to strengthen its financial position and restructure shareholder equity throughout the second quarter of its 2024 financial year, according to its recent Q2 2024…

TuesdayAug 27, 2024 9:00 am

Torr Metals Inc. (TSX.V: TMET): Harnessing the Golden Future of Canada’s Mining Might

Torr Metals is establishing itself as a key player in Canada’s booming mining industry, a global leader in the production of over a dozen essential metals The company's emphasis on early-stage district-scale copper and gold projects underscores a significant ground floor opportunity and growth potential within the sector Building on early successes by leveraging historical data to expand known mineralization trends, Torr Metals is strategically positioned for potential major new discoveries at Kolos, Filion, and Latham, all within close proximity to established provincial and mining infrastructure Canada has long been a global leader in the mining industry. Its vast, mineral-rich…

MondayAug 26, 2024 12:45 pm

AI Innovations at Blockchain Futurist Conference: Experts Discuss the Future of Artificial Intelligence

The Blockchain Futurist Conference, held August 13-14 in Toronto, is Canada’s largest crypto, Web3 and blockchain conference. This year’s highlights included: 10,000+ attendees 250+ speakers 300+ sponsors and partners 130+ press and media 78 events for CanadaCryptoWeek 2 hackathons Key to the event are panel discussions, which spotlight areas of interest and allow attendees to hear and meet with topic experts. These moderated discussions offer ideas and answers from business and technology leaders who are directly involved in rapidly developing subjects of vital interest. In particular, this year’s conference offered interested attendees a special panel discussion centering around one of…

MondayAug 26, 2024 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market

Lexaria, a global innovator in drug delivery platforms, just reported positive results from its applied research program conducted in collaboration with the National Research Council of Canada (“NRC”) The study’s objective was to examine the molecular properties of semaglutide, processed with its patented DehydraTECH(TM) technology, comparing it to Rybelsus(R), the commercially available alternative Lexaria’s DehydraTECH demonstrated that semaglutide can be efficiently released in a simulated gastric fluid environment, without the use of salcaprozate sodium (“SNAC”) ingredient chemistry This milestone moves the company closer to the diabetes treatment market, projected to hit $153.98 billion in value by 2032 Lexaria Bioscience (NASDAQ:…

MondayAug 26, 2024 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Reports Q2, H1 Earnings Growth, Record Profit

Electronic monitoring solutions company SuperCom Ltd. provides a suite of products and services to justice system officials worldwide, promoting public safety through the secure tracking of individuals who require supervision SuperCom’s PureSecurity technology has the ability to serve a wide variety of tracking purposes but is specifically targeting electronic monitoring of offenders, including domestic violence cases, drug rehabilitation services, and probation orders The company recently reported its second quarter and first half financial results, noting growth across multiple metrics, including record profits following a 65.2 percent surge in gross profit and 20.4 percent growth in gross profit margin SuperCom’s EBITDA…

MondayAug 26, 2024 10:59 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces ‘Landmark Agreement’ Providing Exposure to the UAE, Middle East

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a contract worth approximately $210 million. According to the announcement, Volt Mobility, a leading United Arab Emirates (“UAE”)-based commercial leasing company, has entered into a purchase agreement to acquire 3,000 Class 1 and Class 3 EV cargo vans and trucks over a 16-month period. Mullen will receive an initial $3 million deposit within 60 days and additional payments as the EVs are delivered. The company will begin shipping the first vehicles immediately. Mullen expects to recognize approximately $210 million in revenue over the next 16 months of the…

Site Search

Company Search

Month: August 2024